The latest advances in diagnosis, medical management and the status of therapy development for neuromuscular diseases were covered at MDA's 2012 Clinical Conference
The 2012 MDA Clinical Conference, held in Las Vegas March 4 -7, gave more than 500 attendees an opportunity to learn from top experts about the latest advances in diagnosis, medical management and emerging therapies for neuromuscular diseases.
The conference was designed to provide MDA clinic directors and clinic team members with updates covering a number of diseases in MDA’s program, including the muscular dystrophies, inherited neuropathies, motor neuron diseases and immune-modulated neuromuscular diseases. MDA maintains some 200 medical clinics (including 41 MDA/ALS centers) across the country.
About half the conference participants were physicians from such specialties as neurology, physical medicine and rehabilitation, cardiology and pulmonology. Participants also included nurses, nurse practitioners, therapists, genetic counselors, social workers and MDA health care service coordinators.
Held at the South Point Hotel, the conference was co-chaired by longtime MDA clinic directors and research grantees Jerry Mendell, of Nationwide Children's Hospital in Columbus, Ohio, and Michael Shy, of University of Iowa Hospitals & Clinics.
In 33 presentations over two-and-a-half days, participants learned about recent advances in:
More specifics about these presentations will be posted on MDA’s website during the coming weeks.
Four individuals posted daily blogs about the proceedings, which are available on the conference blog page. These blogs provide an overview of several of the lectures, as well as personal perspectives.
This is the second conference in MDA's new annual national conference series, which was launched with the Association's Scientific Conference in March 2011.